VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$80.5M
Cap. Flow %
29.85%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

1
O icon
Realty Income
O
+$925K
2
LLY icon
Eli Lilly
LLY
+$843K
3
MRNA icon
Moderna
MRNA
+$824K
4
PFE icon
Pfizer
PFE
+$803K
5
MRK icon
Merck
MRK
+$796K

Top Sells

1
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
+$1.76M
2
AEM icon
Agnico Eagle Mines
AEM
+$1.5M
3
MOS icon
The Mosaic Company
MOS
+$716K
4
STR
Sitio Royalties
STR
+$468K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$424K

Sector Composition

1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GLAD icon
251
Gladstone Capital
GLAD
$582M
$411K 0.15%
20,367
-3,687
-15% -$74.4K
OCSL icon
252
Oaktree Specialty Lending
OCSL
$1.23B
$409K 0.15%
20,813
+1,054
+5% +$20.7K
BRW
253
Saba Capital Income & Opportunities Fund
BRW
$351M
$404K 0.15%
50,372
-634
-1% -$5.09K
CCAP icon
254
Crescent Capital BDC
CCAP
$588M
$404K 0.15%
26,052
+221
+0.9% +$3.43K
AXSM icon
255
Axsome Therapeutics
AXSM
$6.45B
$393K 0.15%
10,259
+5,206
+103% +$199K
BBDC icon
256
Barings BDC
BBDC
$993M
$389K 0.14%
41,774
-4,520
-10% -$42.1K
PTCT icon
257
PTC Therapeutics
PTCT
$4.52B
$362K 0.13%
9,043
-991
-10% -$39.7K
GAIN icon
258
Gladstone Investment Corp
GAIN
$543M
$347K 0.13%
24,665
-2,280
-8% -$32.1K
ZLAB icon
259
Zai Lab
ZLAB
$3.49B
$335K 0.12%
9,669
+3,736
+63% +$129K
GBT
260
DELISTED
Global Blood Therapeutics, Inc.
GBT
$332K 0.12%
10,406
-4,532
-30% -$145K
BBIO icon
261
BridgeBio Pharma
BBIO
$10.4B
$324K 0.12%
35,646
+31,589
+779% +$287K
IMCR icon
262
Immunocore
IMCR
$1.85B
$318K 0.12%
8,513
+3,297
+63% +$123K
FOLD icon
263
Amicus Therapeutics
FOLD
$2.46B
$314K 0.12%
29,263
-6,537
-18% -$70.1K
BCIC
264
BCP Investment Corporation Common Stock
BCIC
$160M
$303K 0.11%
12,931
-54
-0.4% -$1.27K
AGIO icon
265
Agios Pharmaceuticals
AGIO
$2.12B
$302K 0.11%
13,602
+2,061
+18% +$45.8K
RARE icon
266
Ultragenyx Pharmaceutical
RARE
$3.04B
$292K 0.11%
4,895
+345
+8% +$20.6K
LEGN icon
267
Legend Biotech
LEGN
$6.39B
$290K 0.11%
5,274
+2,079
+65% +$114K
BTX
268
BlackRock Technology and Private Equity Term Trust
BTX
$819M
$289K 0.11%
36,387
+22,786
+168% +$181K
ONC
269
BeOne Medicines Ltd. American Depositary Shares
ONC
$38.1B
$285K 0.11%
1,758
+422
+32% +$68.4K
SGEN
270
DELISTED
Seagen Inc. Common Stock
SGEN
$284K 0.11%
1,604
-971
-38% -$172K
DCPH
271
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$282K 0.1%
+21,427
New +$282K
MYOV
272
DELISTED
Myovant Sciences Ltd.
MYOV
$278K 0.1%
22,356
+11,701
+110% +$146K
LGND icon
273
Ligand Pharmaceuticals
LGND
$3.23B
$277K 0.1%
4,974
+809
+19% +$45.1K
FCRD
274
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$275K 0.1%
78,239
+5,870
+8% +$20.6K
ENTA icon
275
Enanta Pharmaceuticals
ENTA
$190M
$274K 0.1%
5,798
+445
+8% +$21K
9 10
11
12 13